Evidence map›Paper›PMID 24335487›Full record

ReviewVirulence2014

Severe sepsis and septic shock: management and performance improvement.

Christa A Schorr, Sergio Zanotti, R Phillip Dellinger

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Virulence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07172451 (Efficacy and Safety of Balanced Gelatin Solution for Fluid Infusion in Sepsis Patients Undergoing Emergency Abdominal Surgery), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07172451 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Balanced Gelatin Solution for Fluid Infusion in Sepsis Patients Undergoing Emergency Abdominal Surgery: A Multicenter, Adaptive Designed, Randomized Controlled Trial

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2026 to 2028Enrolled318ConditionsSepsis, Intra-Abdominal InfectionsArmsBalanced Gelatin Solution, Acetate Ringer's Solution
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Observational
  20. Diagnosing sepsis - The role of laboratory medicine.Clinica chimica acta; international journal of clinical chemistry · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christa A SchorrDivision of Critical Care Medicine; Department of Medicine; Cooper University Hospital; Camden, NJ USA.
Sergio ZanottiDivision of Critical Care Medicine; Department of Medicine; Cooper University Hospital; Camden, NJ USA.
R Phillip DellingerDivision of Critical Care Medicine; Department of Medicine; Cooper University Hospital; Camden, NJ USA.
Cooper University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morbidity and mortality from sepsis remains unacceptably high. Large variability in clinical practice, plus the increasing awareness that certain processes of care associated with improved critical care outcomes, has led to the development of clinical practice guidelines in a variety of areas related to infection and sepsis. The Surviving Sepsis Guidelines for Management of Severe Sepsis and Septic Shock were first published in 2004, revised in 2008, and recently revised again and published in 2013. The first part of this manuscript is a summary of the 2013 guidelines with some editorial comment. The second part of the manuscript characterizes hospital based sepsis performance improvement programs and highlights the sepsis bundles from the Surviving Sepsis Campaign as a key component of such a program.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsBiomarkersCritical CareHumansShock, SepticSteroidsTreatment OutcomeAnti-Bacterial AgentsBiomarkersSteroidsguidelinesperformance improvementresuscitationsepsis bundlessevere sepsis

Identifiers

PMID24335487
PMCPMC3916373
OpenAlexW1997996370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.